STOCK TITAN
  1. Home
  2. Sec-filings
  3. UNH
  4. [Form 4] UNITEDHEALTH GROUP INC Insider Trading Activity

UnitedHealth (NYSE: UNH) legal chief granted 60.691 dividend-equivalent shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zaetta Christopher R reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC EVP & Chief Legal Officer Christopher R. Zaetta received 60.691 shares of common stock as a grant of dividend equivalents tied to existing restricted stock units. The award carried no purchase price and increased his directly held common stock to 15,859.84 shares.

The dividend equivalents will vest or be forfeited under the same terms as the underlying restricted stock units. A separate June 8, 2026 transfer of shares and options was exempt from Section 16 reporting under applicable SEC rules.

Positive

  • None.

Negative

  • None.
Insider Zaetta Christopher R
Role EVP & Chief Legal Officer
Type Security Shares Price Value
Grant/Award Common Stock 60.691 $0.00 --
Holdings After Transaction: Common Stock — 15,859.84 shares (Direct, null)
Footnotes (1)
  1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. On June 8, 2026, the reporting person transferred 783 shares of UNH common stock and stock options covering an aggregate of 8,771 shares of UNH common stock. The stock options have different exercise prices. This transfer was exempt from Section 16 reporting pursuant to applicable SEC rules.
Shares acquired 60.691 shares Dividend-equivalent grant on restricted stock units on June 23, 2026
Grant price $0.0000 per share Compensation-related award, not an open-market purchase
Post-transaction holdings 15,859.84 shares Direct common stock held after the June 23, 2026 grant
Transferred common shares 783 shares June 8, 2026 transfer exempt from Section 16 reporting
Transferred option coverage 8,771 shares Underlying shares for transferred stock options on June 8, 2026
dividend equivalents financial
"Represents dividend equivalents paid on outstanding restricted stock units."
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
restricted stock units financial
"The dividend equivalents are subject to the same terms as the underlying restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Section 16 reporting regulatory
"This transfer was exempt from Section 16 reporting pursuant to applicable SEC rules."
grant, award, or other acquisition regulatory
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zaetta Christopher R
(Last)(First)(Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE
(Street)
EDEN PRAIRIE MINNESOTA 55344
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/23/2026A60.691(1)A$015,859.84(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
2. On June 8, 2026, the reporting person transferred 783 shares of UNH common stock and stock options covering an aggregate of 8,771 shares of UNH common stock. The stock options have different exercise prices. This transfer was exempt from Section 16 reporting pursuant to applicable SEC rules.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Christopher R. Zaetta06/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did UNITEDHEALTH GROUP (UNH) report for Christopher R. Zaetta?

Christopher R. Zaetta, EVP & Chief Legal Officer, received 60.691 shares of UNITEDHEALTH GROUP common stock. These shares represent dividend equivalents credited on his outstanding restricted stock units and were granted at no cost, increasing his directly held position to 15,859.84 shares.

What is the nature of the 60.691 UNH shares acquired by Christopher R. Zaetta?

The 60.691 UNH shares are dividend equivalents on outstanding restricted stock units. They mirror cash dividends paid on common stock and are subject to the same vesting and forfeiture conditions as the underlying restricted stock units, rather than being an open-market purchase.

Did Christopher R. Zaetta pay anything for the 60.691 UNH shares he acquired?

He paid nothing for the 60.691 shares. The shares were granted at a per-share price of $0.0000 as dividend equivalents on existing restricted stock units, making this a compensation-related award rather than a market transaction or open-market purchase of UNITEDHEALTH GROUP stock.

How many UNITEDHEALTH GROUP (UNH) shares does Christopher R. Zaetta hold after this Form 4 transaction?

After receiving the 60.691 dividend-equivalent shares, Christopher R. Zaetta directly holds 15,859.84 shares of UNITEDHEALTH GROUP common stock. This figure reflects his post-transaction direct ownership reported in the Form 4 for the June 23, 2026 award event.

What does the Form 4 say about the vesting conditions for Zaetta’s new UNH shares?

The Form 4 states these dividend-equivalent shares are subject to the same terms as the underlying restricted stock units. This means they vest on the same schedule and are forfeited if the related restricted stock units do not vest under UNITEDHEALTH GROUP’s equity compensation arrangements.

Was there any other notable equity movement involving Christopher R. Zaetta mentioned in this filing?

Yes. A footnote explains that on June 8, 2026, he transferred 783 shares of UNH common stock and stock options covering 8,771 shares. This transfer was exempt from Section 16 reporting under applicable SEC rules and therefore not reported as a Form 4 transaction.